Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of efficacy of Diphereline and Variopeptyl in idiopathic central precocious puberty
IRCT20170225032759N1Phase 2Completed
- Sponsor
- Private Health Management
- Start
- Jan 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of triptorelin in Idiopathic precocious puberty (CPP) (2 arms), sponsored by Private Health Management. Started Jan 2016; status: completed.
02
Drugs
triptorelin
03
Conditions
Idiopathic precocious puberty (CPP)
Beyond the preview
Go deeper on IRCT20170225032759N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170225032759N1.